Canadian professional groups recommended deprescribing proton pump inhibitors (PPIs) in adults who have completed a minimum of 4 weeks of PPI treatment for heartburn or mild to moderate gastroesophageal reflux disease or esophagitis, and whose symptoms are resolved. Deprescirbing by decreasing the daily dose or stopping and changing to on-demand (as needed) use of PPIs or considering histamine-2 receptor antagonist as an alternative to PPIs, after 4 weeks of treatment when symptoms have resolved. However, the recommendations do not apply to those who have or have had Barrett esophagus, severe esophagitis grade C or D, or documented history of bleeding gastrointestinal ulcers. There is growing concern about overuse of PPIs. Source: https://www.ti.ubc.ca/; http://www.cfp.ca/
A US prospective study found that moderate egg consumption was associated with a significantly lower…
Anxiety disorders are common yet often underrecognized in primary care, but a review shows that…
Two-dose recombinant zoster vaccination (RZV) was associated with a significantly lower risk of new-onset dementia,…
A 13-year follow-up of a randomized controlled trial found that a single colonoscopy screening significantly…
Higher consumption of ultra-processed foods (UPFs) is associated with poorer attention and increased modifiable dementia…
Blood pressure (BP)-lowering treatment significantly reduces the risk of major cardiovascular events in individuals with…
This website uses cookies.